References
- Budek G. 2012. 3rd World Congress on Nanomedicine, International Society for Nanomedicine.
- Chang TMS. 1964. Semipermeable microcapsules. Science, 146: 524–525.
- Chang TMS, Poznansky MJ. 1968. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 218:242–45.
- Chang TMS. 1971. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma.Nature 229:117–118.
- Chang TMS. May 2007. Monograph on “ARTIFICIAL CELLS: biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation, cell/stem cell therapy” World Scientific Publisher/Imperial College Press 435 pages (monograph available for free access on www.artcell.mcgill.ca).
- Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. 2008. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopaedic surgery. J Traum., 64:1484–97.
- Moore E, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ, Gomez GA, Cipolle MD, Rodman GH, Jr, Malangoni MA, Hides GA, Omert LA, Gould SA. 2009. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the multicenter trial. Journal of the American College of Surgeons, 208: 1–13.
- Poncelet D, Neufeld R, Gu F. 2012. 20th International Conference on Bioencapsulation, Bioencapsulation Research Group.
- Winslow, R. 2006 [ed] Blood Substitutes, San Diego Academic Press.